RecruitingNot ApplicableNCT06951386

The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for Metabolic Syndrome

The Impact of 12 Weeks Intervention With Plant-based Oat Drink Rich in Short-chain Fatty Acids on Postprandial Lipidemia in Individuals at Risk for Metabolic Syndrome


Sponsor

KU Leuven

Enrollment

50 participants

Start Date

Feb 11, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

During this study, the effect of short-chain fatty acids on blood lipaedemia, glycemia, anthropometrics, blood pressure and energy expenditure will be investigated.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying unenriched oat drink and with short-chain fatty acids enriched drink for people with anthropometry, blood pressure, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTwith short-chain fatty acids enriched drink

Oat-based drink enriched with 15 g/L short-chain fatty acids

DIETARY_SUPPLEMENTunenriched oat drink

Oat-based drink


Locations(1)

KU Leuven/ UZ Leuven

Leuven, Vlaams-Brabant, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06951386


Related Trials